Effect of Pioglitazone and Risk of Atrial Fibrillation in Diabetics with Stable Coronary Artery Disease

Authors

Andrew Abraham
Hussein Noureldine
Qusai Alqudah
Sanaullah Mojadeddi
Rabab Elsadek
Ajapall Gill
Christopher Bray

Author Institutions

HCA Healthcare

Publication Date

01-01-2024

Document Type

Poster

Fulltext URL

https://scholarlycommons.hcahealthcare.com/context/northflorida2024/article/1019/viewcontent

URL

http://scholarlycommons.hcahealthcare.com/northflorida2024/20

Bp Author Id

3bf66a35-d1ea-46da-b0fe-f5f1eaf7333e
d9d0f01b-b8db-4324-ba8b-17179c82814b
c08cd599-34c1-456b-abd9-b95a4d749f16
51cf5310-99b6-4cff-bd7e-04190d6d9504
669216d2-fcfb-4ee0-8f12-a57ee3697941

Division

North Florida

Hospital

HCA Florida North Florida Hospital

Publisher

HCA Healthcare Graduate Medical Education

Relationshiptofacility

Resident/Fellow

Specialty

Internal Medicine

Upload Cover Image

use_pdf

Discipline

Cardiovascular Diseases
Diseases
Internal Medicine
Medical Specialties
Medicine and Health Sciences

Download Link

https://scholarlycommons.hcahealthcare.com/cgi/viewcontent.cgi?article=1019&context=northflorida2024

Institution

HCA Healthcare
UCF/HCA North Florida Hospital
University of Central Florida

HCA Healthcare Graduate Medical Education 2024 Research Days

Effect of Pioglitazone and Risk of Atrial Fibrillation in Diabetics with Stable Coronary Artery Disease